{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:06:18Z","timestamp":1790838378470,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006021","name":"Direction G\u00e9n\u00e9rale de l\u2019Armement","doi-asserted-by":"publisher","award":["PDH-2-NRBC-5-C-4210"],"award-info":[{"award-number":["PDH-2-NRBC-5-C-4210"]}],"id":[{"id":"10.13039\/501100006021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020913","name":"Service de Sant\u00e9 des Arm\u00e9es","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016398","name":"Minist\u00e8re des Arm\u00e9es","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-19-CE39-0009"],"award-info":[{"award-number":["ANR-19-CE39-0009"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.cbi.2024.110929","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T04:49:36Z","timestamp":1709095776000},"page":"110929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["No-observed-adverse-effect-level (NOAEL) assessment as an optimized dose of cholinesterase reactivators for the treatment of exposure to warfare nerve agents in mice"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3623-0943","authenticated-orcid":false,"given":"Maril\u00e8ne","family":"Trancart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4095-7854","authenticated-orcid":false,"given":"Anne-Sophie","family":"Hanak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Dambrune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9liati","family":"Madi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Voros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Baati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7471-8953","authenticated-orcid":false,"given":"Andr\u00e9-Guilhem","family":"Calas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.110929_bib1","article-title":"Acute Health effects and outcome following sarin gas attacks in khan shaykhun, Syria","volume":"14","author":"Alsaleh","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.cbi.2024.110929_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11419-017-0376-7","article-title":"Fatal sarin poisoning in Syria 2013: forensic verification within an international laboratory network","volume":"36","author":"John","year":"2018","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.cbi.2024.110929_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/24734306.2017.1373503","article-title":"Toxic chemical weapons of assassination and warfare: nerve agents VX and sarin","volume":"1","author":"Chai","year":"2017","journal-title":"Toxicol Commun"},{"key":"10.1016\/j.cbi.2024.110929_bib4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s11419-018-0426-9","article-title":"Murders with VX: aum shinrikyo in Japan and the assassination of kim jong-nam in Malaysia","volume":"36","author":"Nakagawa","year":"2018","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.cbi.2024.110929_bib5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/15563650.2018.1469759","article-title":"Novichok: a murderous nerve agent attack in the UK","volume":"56","author":"Vale","year":"2018","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.cbi.2024.110929_bib6","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.181831","article-title":"Theoretical study of the molecular aspect of the suspected novichok agent A234 of the Skripal poisoning","volume":"6","author":"Bhakhoa","year":"2019","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.cbi.2024.110929_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(20)32644-1","article-title":"Novichok nerve agent poisoning","volume":"397","author":"Steindl","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2024.110929_bib8","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1056\/NEJMra1705224","article-title":"Toxidrome recognition in chemical-weapons attacks","volume":"378","author":"Ciottone","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2024.110929_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.emc.2014.09.010","article-title":"Organophosphate and carbamate poisoning","volume":"33","author":"King","year":"2015","journal-title":"Emerg. Med. Clin."},{"key":"10.1016\/j.cbi.2024.110929_bib10","article-title":"Respiratory failure following organophosphate poisoning: a literature review","volume":"9","author":"Giyanwani","year":"2017","journal-title":"Cureus"},{"issue":"Suppl 2","key":"10.1016\/j.cbi.2024.110929_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jnc.14026","article-title":"Cholinesterase reactivators and bioscavengers for pre- and post-exposure treatments of organophosphorus poisoning","volume":"142","author":"Masson","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2024.110929_bib12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/092986708783955563","article-title":"Entry of oximes into the brain: a review","volume":"15","author":"Lorke","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110929_bib13","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00204-020-02797-0","article-title":"Organophosphorus compounds and oximes: a critical review","volume":"94","author":"Worek","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2024.110929_bib14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3109\/14756360903433373","article-title":"A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques","volume":"25","author":"Bajgar","year":"2010","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110929_bib15","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1021\/acs.jmedchem.1c01748","article-title":"A new class of Bi- and trifunctional sugar oximes as antidotes against organophosphorus poisoning","volume":"65","author":"Da Silva","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110929_bib16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00204-021-02981-w","article-title":"Development of versatile and potent monoquaternary reactivators of acetylcholinesterase","volume":"95","author":"Gorecki","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2024.110929_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.14352","article-title":"Central neuroprotection demonstrated by novel oxime countermeasures to nerve agent surrogates","volume":"1479","author":"Chambers","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cbi.2024.110929_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3109\/15376510903350371","article-title":"The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice","volume":"19","author":"Kassa","year":"2009","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.cbi.2024.110929_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuro.2016.05.006","article-title":"Therapeutic and reactivating efficacy of oximes K027 and K203 against a direct acetylcholinesterase inhibitor","volume":"55","author":"Antonijevic","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2024.110929_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1124\/jpet.118.249383","article-title":"Pharmacology, pharmacokinetics, and tissue disposition of zwitterionic hydroxyiminoacetamido alkylamines as reactivating antidotes for organophosphate exposure","volume":"367","author":"Sit","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2024.110929_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cbi.2008.04.011","article-title":"Oximes: reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning","volume":"175","author":"Kovarik","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110929_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbi.2016.03.009","article-title":"An easy method for the determination of active concentrations of cholinesterase reactivators in blood samples: application to the efficacy assessment of non quaternary reactivators compared to HI-6 and pralidoxime in VX-poisoned mice","volume":"267","author":"Calas","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110929_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/157340710790711764","article-title":"Cholinesterase interactions with oximes","volume":"6","author":"Kovarik","year":"2010","journal-title":"Curr. Bioact. Compd."},{"key":"10.1016\/j.cbi.2024.110929_bib24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bcp.2010.05.022","article-title":"Kinetic analysis of interactions between alkylene-linked bis-pyridiniumaldoximes and human acetylcholinesterases inhibited by various organophosphorus compounds","volume":"80","author":"Wille","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110929_bib25","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1164\/rccm.201406-1150CI","article-title":"Respiratory complications of organophosphorus nerve agent and insecticide poisoning. Implications for respiratory and critical care","volume":"190","author":"Hulse","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2024.110929_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/biom10060858","article-title":"Efficacy assessment of an uncharged reactivator of NOP-inhibited acetylcholinesterase based on tetrahydroacridine pyridine-aldoxime hybrid in mouse compared to pralidoxime","volume":"10","author":"Calas","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.cbi.2024.110929_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2019.06.003","article-title":"Respiratory failure triggered by cholinesterase inhibitors may involve activation of a reflex sensory pathway by acetylcholine spillover","volume":"424","author":"Nervo","year":"2019","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2024.110929_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.cbi.2024.110929_bib29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/01621459.1965.10480843","article-title":"The up-and-down method for small samples","volume":"60","author":"Dixon","year":"1965","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.cbi.2024.110929_bib30","series-title":"Guidance Document on Acute Oral Toxicity Testing","first-page":"1","year":"2001"},{"key":"10.1016\/j.cbi.2024.110929_bib31","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1021\/ja804941z","article-title":"Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation","volume":"130","author":"Carletti","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2024.110929_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110929_bib33","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.biochi.2011.06.023","article-title":"Mechanism of stereoselective interaction between butyrylcholinesterase and ethopropazine enantiomers","volume":"93","author":"Sinko","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.cbi.2024.110929_bib34","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00204-012-0977-1","article-title":"The summary on non-reactivation cholinergic properties of oxime reactivators: the interaction with muscarinic and nicotinic receptors","volume":"87","author":"Soukup","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2024.110929_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114776","article-title":"Pharmacological and toxicological in vitro and in vivo effect of higher doses of oxime reactivators","volume":"383","author":"Hepnarova","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110929_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110061","article-title":"Supplemental treatment to atropine improves the efficacy to reverse nerve agent induced bronchoconstriction","volume":"364","author":"Wigenstam","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110929_bib37","series-title":"Guidance for Industry M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals","year":"2010"},{"key":"10.1016\/j.cbi.2024.110929_bib38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/15563650600584519","article-title":"Civilian adult self injections of atropine-trimedoxime (TMB4) auto-injectors","volume":"44","author":"Bentur","year":"2006","journal-title":"Clin. Toxicol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:51:48Z","timestamp":1762113108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":38,"alternative-id":["S0009279724000759"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.110929","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No-observed-adverse-effect-level (NOAEL) assessment as an optimized dose of cholinesterase reactivators for the treatment of exposure to warfare nerve agents in mice","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.110929","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110929"}}